- H
Hemab
- Kristen Pappas
Kristen Pappas is an experienced professional in clinical operations with a background in leading teams and managing clinical trials. As the Vice President and Head of Clinical Operations at Hemab Therapeutics, Kristen oversees strategic operational aspects of clinical development. Prior experience includes serving as Senior Manager and Clinical Operations Lead at Biogen, as well as working as a Contractor and Clinical Trial Manager at Acceleron Pharma. Additionally, Kristen has contributed to community engagement as Co-Chair of Community Connections at the Family Action Network.
Previous companies
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Hemab
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
